Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Anirvan_Ghosh
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
age-related diseases
senolytic medicines |
| gptkbp:foundedYear |
2011
|
| gptkbp:founder |
gptkb:Daohong_Zhou
gptkb:Jan_van_Deursen gptkb:Jing_Yang gptkb:Judith_Campisi gptkb:Nathaniel_David gptkb:Ned_David gptkb:Peter_de_Keizer |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Unity Biotechnology
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:UBX1325
gptkb:UBX1967 |
| gptkbp:numberOfEmployees |
approximately 60 (2023)
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:researchArea |
osteoarthritis
ophthalmology cellular senescence |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:UBX
|
| gptkbp:website |
https://unitybiotechnology.com/
|
| gptkbp:bfsParent |
gptkb:Peter_Thiel
|
| gptkbp:bfsLayer |
4
|